Clinical Course of Hepatitis B Viral Infection in Patients Undergoing Anti-Tumor Necrosis Factor α Therapy for Inflammatory Bowel Disease

BACKGROUND/AIMS: Little is known about the clinical course of hepatitis B virus (HBV)-infected patients undergoing anti-tumor necrosis factor α (TNF-α) therapy for inflammatory bowel disease (IBD). We aimed to investigate the clinical course of HBV infection and IBD and to analyze liver dysfunction...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ji Min, Wei, Shu-Chen, Lee, Kang-Moon, Ye, Byong Duk, Mao, Ren, Kim, Hyun-Soo, Park, Soo Jung, Park, Sang Hyoung, Oh, Eun Hye, Im, Jong Pil, Jang, Byung Ik, Kim, Dae Bum, Takeuchi, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099383/
https://www.ncbi.nlm.nih.gov/pubmed/34593670
http://dx.doi.org/10.5009/gnl210081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099383/
https://www.ncbi.nlm.nih.gov/pubmed/34593670
http://dx.doi.org/10.5009/gnl210081

Ejemplares similares